Cellective BioTherapy
Skip to content
  • About Us
    • Leadership Team
    • Board of Directors
  • Our Science
    • Technology
    • Publications
  • Pipeline
  • News
  • Investors
  • Careers

Fred Eshelman makes another investment, this time in a Duke spinout

Posted on: June 12, 2015

Recent article from The Triangle Business Journal detailing the recent Eshelman investment in Cellective BioTherapy.

 

This entry was tagged Duke University spinout, Fred Eshelman. Bookmark the permalink.

Post navigation

Announcing the new Cellective BioTherapy website →

Main Menu

  • About Us
  • Our Science
  • Pipeline
  • News
  • Investors
  • Careers

Other Links

  • Contact Us
  • Privacy Policy
  • Terms of Use
 

©2018 - Cellective BioTherapy, Inc.

Zerif Lite developed by ThemeIsle